fashion -WSS

fashion

author：fashion 2025-10-02 22:41:17 - browse：9

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Florida Supreme Court upholds state's abortion ban

leisure time

WSS

Lung cancer screening guidelines updated for cigarette smokers

Lung cancer screening guidelines updated for cigarette smokers

Drug companies' payments and gifts affect physicians' prescribing

How to convince healthy people to buy insurance

Covid silver lining: Unprecedented look at human immune system

UnitedHealth, in a surprise, takes aim at Steward’s physician group

hotspot

fashion

explore

Peter Hotez and the public health issue of online harassment

Humans aren't the only ones with an imagination. Rats have it too

As demand for Covid shots wanes, Moderna seeks its next success

Hundreds died while taking an arthritis drug, but nobody alerted patients

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Live blog: Hearing on CRISPR

In age of alternative facts, a scholarly course on calling out crap

Scientists uncover potential path to treating deadly childhood tumor

DIEP, the 'gold standard' of breast reconstruction, is under threat

Coloradans with cystic fibrosis could lose access to Trikafta

Wikipedia

Drug companies' payments and gifts affect physicians' prescribing

First Opinion on colorectal cancer screening: letter and response

The health care issue Democrats can’t solve: hospital reform

Covid silver lining: Unprecedented look at human immune system

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Live blog: Hearing on CRISPR

hotspot

hotspot

leisure time

leisure time